{"id":"https://openalex.org/W1973333409","doi":"https://doi.org/10.1046/j.1365-2249.2002.02002.x","title":"Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept","display_name":"Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept","publication_year":2002,"publication_date":"2002-11-24","ids":{"openalex":"https://openalex.org/W1973333409","doi":"https://doi.org/10.1046/j.1365-2249.2002.02002.x","mag":"1973333409","pmid":"https://pubmed.ncbi.nlm.nih.gov/12452839","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1906535"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2249.2002.02002.x","doi":"https://doi.org/10.1046/j.1365-2249.2002.02002.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2249.2002.02002.x","pdf_url":null,"source":{"id":"https://openalex.org/S11896317","display_name":"Clinical & Experimental Immunology","issn_l":"0009-9104","issn":["0009-9104","1365-2249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1906535","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032223113","display_name":"Peter D. Arkwright","orcid":"https://orcid.org/0000-0002-7411-5375","observed_orcids":["https://orcid.org/0000-0002-7411-5375"]},"institutions":[{"id":"https://openalex.org/I4210087748","display_name":"St Mary's Hospital","ror":"https://ror.org/001x4vz59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800602287","https://openalex.org/I4210087748","https://openalex.org/I4210092852"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"P D ARKWRIGHT","raw_affiliation_strings":["Academic Unit of Child Health, St Mary's Hospital, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Unit of Child Health, St Mary's Hospital, Manchester, UK","institution_ids":["https://openalex.org/I4210087748"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060095007","display_name":"Michael McDermott","orcid":"https://orcid.org/0000-0002-1015-0745","observed_orcids":["https://orcid.org/0000-0002-1015-0745"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801259928","display_name":"Royal London Hospital","ror":"https://ror.org/019my5047","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M F MCDERMOTT","raw_affiliation_strings":["Departments of Diabetes Metabolic Medicine and Immunology, Barts and The London Hospital, Queen Mary's School of Medicine and Dentistry, University of London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Diabetes Metabolic Medicine and Immunology, Barts and The London Hospital, Queen Mary's School of Medicine and Dentistry, University of London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801259928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027726446","display_name":"Sander M. Houten","orcid":"https://orcid.org/0000-0002-6167-9147","observed_orcids":["https://orcid.org/0000-0002-6167-9147"]},"institutions":[{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"S M HOUTEN","raw_affiliation_strings":["Laboratory Genetic Metabolic Diseases, University of Amsterdam, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Genetic Metabolic Diseases, University of Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112161839","display_name":"Joost Frenkel","orcid":"https://orcid.org/0000-0002-0200-5425","observed_orcids":["https://orcid.org/0000-0002-0200-5425"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]},{"id":"https://openalex.org/I4210162850","display_name":"Wilhelmina Children's Hospital","ror":"https://ror.org/05fqypv61","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916","https://openalex.org/I4210162850"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J FRENKEL","raw_affiliation_strings":["Division of Paediatrics, Wilhelmina Children's Hospital, University Medical Center, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Paediatrics, Wilhelmina Children's Hospital, University Medical Center, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916","https://openalex.org/I4210162850"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057865344","display_name":"Hans R. Waterham","orcid":"https://orcid.org/0000-0001-5147-7106","observed_orcids":["https://orcid.org/0000-0001-5147-7106"]},"institutions":[{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"H R WATERHAM","raw_affiliation_strings":["Laboratory Genetic Metabolic Diseases, University of Amsterdam, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Genetic Metabolic Diseases, University of Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113593121","display_name":"E Aganna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801259928","display_name":"Royal London Hospital","ror":"https://ror.org/019my5047","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"E AGANNA","raw_affiliation_strings":["Departments of Diabetes Metabolic Medicine and Immunology, Barts and The London Hospital, Queen Mary's School of Medicine and Dentistry, University of London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Diabetes Metabolic Medicine and Immunology, Barts and The London Hospital, Queen Mary's School of Medicine and Dentistry, University of London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801259928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110034397","display_name":"LINDA J. HAMMOND","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801259928","display_name":"Royal London Hospital","ror":"https://ror.org/019my5047","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L J HAMMOND","raw_affiliation_strings":["Departments of Diabetes Metabolic Medicine and Immunology, Barts and The London Hospital, Queen Mary's School of Medicine and Dentistry, University of London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Diabetes Metabolic Medicine and Immunology, Barts and The London Hospital, Queen Mary's School of Medicine and Dentistry, University of London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801259928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058372952","display_name":"Rita M. Mirakian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801259928","display_name":"Royal London Hospital","ror":"https://ror.org/019my5047","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R M MIRAKIAN","raw_affiliation_strings":["Departments of Diabetes Metabolic Medicine and Immunology, Barts and The London Hospital, Queen Mary's School of Medicine and Dentistry, University of London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Diabetes Metabolic Medicine and Immunology, Barts and The London Hospital, Queen Mary's School of Medicine and Dentistry, University of London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801259928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109550410","display_name":"Pamela Tomlin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210154214","display_name":"Royal Preston Hospital","ror":"https://ror.org/05kpx1157","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1293129422","https://openalex.org/I4210154214"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P I TOMLIN","raw_affiliation_strings":["Royal Preston Hospital, Preston, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Preston Hospital, Preston, UK","institution_ids":["https://openalex.org/I4210154214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017926409","display_name":"P I VIJAYDURAI","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210154214","display_name":"Royal Preston Hospital","ror":"https://ror.org/05kpx1157","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1293129422","https://openalex.org/I4210154214"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P I VIJAYDURAI","raw_affiliation_strings":["Royal Preston Hospital, Preston, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Preston Hospital, Preston, UK","institution_ids":["https://openalex.org/I4210154214"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014990865","display_name":"Andrew J Cant","orcid":"https://orcid.org/0009-0001-4034-4153","observed_orcids":["https://orcid.org/0009-0001-4034-4153"]},"institutions":[{"id":"https://openalex.org/I4210124950","display_name":"Newcastle upon Tyne Hospital","ror":"https://ror.org/02w91w637","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210109172","https://openalex.org/I4210124950"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A J CANT","raw_affiliation_strings":["Supra-regional Children's Bone Marrow Transplantation Unit, Newcastle General Hospital, Newcastle upon Tyne, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Supra-regional Children's Bone Marrow Transplantation Unit, Newcastle General Hospital, Newcastle upon Tyne, UK","institution_ids":["https://openalex.org/I4210124950"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5032223113"],"corresponding_institution_ids":["https://openalex.org/I4210087748"],"apc_list":{"value":2894,"currency":"GBP","value_usd":3816},"apc_paid":null,"fwci":1.9121,"has_fulltext":false,"cited_by_count":68,"citation_normalized_percentile":{"value":0.84996351,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"130","issue":"3","first_page":"484","last_page":"488"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11078","display_name":"Inflammasome and immune disorders","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11078","display_name":"Inflammasome and immune disorders","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hyper-igd-syndrome","display_name":"hyper-IgD syndrome","score":0.8510000109672546},{"id":"https://openalex.org/keywords/periodic-fever-syndromes","display_name":"periodic fever syndromes","score":0.8330000042915344},{"id":"https://openalex.org/keywords/mevalonate-kinase","display_name":"mevalonate kinase","score":0.7950000166893005},{"id":"https://openalex.org/keywords/tnfrsf1a","display_name":"TNFRSF1A","score":0.8849999904632568},{"id":"https://openalex.org/keywords/traps","display_name":"traps","score":0.6980000138282776},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":0.8450000286102295},{"id":"https://openalex.org/keywords/receptor-shedding","display_name":"receptor shedding","score":0.8090000152587891},{"id":"https://openalex.org/keywords/monocytes","display_name":"monocytes","score":0.9810000061988831},{"id":"https://openalex.org/keywords/genetic-screening","display_name":"genetic screening","score":0.3790000081062317}],"concepts":[{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.7647905945777893},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.607379138469696},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.580845057964325},{"id":"https://openalex.org/C48010095","wikidata":"https://www.wikidata.org/wiki/Q79447","display_name":"Immunoglobulin D","level":4,"score":0.5522413849830627},{"id":"https://openalex.org/C188997412","wikidata":"https://www.wikidata.org/wiki/Q1640386","display_name":"Proband","level":4,"score":0.4545523226261139},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.320378839969635},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.30015790462493896},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.265034556388855},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.18480989336967468},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.16748496890068054},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1379871964454651},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000068800","descriptor_name":"Etanercept","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004252","descriptor_name":"DNA Mutational Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008798","descriptor_name":"Mevalonic Acid","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010375","descriptor_name":"Pedigree","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010505","descriptor_name":"Familial Mediterranean Fever","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010505","descriptor_name":"Familial Mediterranean Fever","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010505","descriptor_name":"Familial Mediterranean Fever","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D017853","descriptor_name":"Phosphotransferases (Alcohol Group Acceptor)","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018124","descriptor_name":"Receptors, Tumor Necrosis Factor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018124","descriptor_name":"Receptors, Tumor Necrosis Factor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018124","descriptor_name":"Receptors, Tumor Necrosis Factor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D018124","descriptor_name":"Receptors, Tumor Necrosis Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D047888","descriptor_name":"Receptors, Tumor Necrosis Factor, Type I","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1046/j.1365-2249.2002.02002.x","doi":"https://doi.org/10.1046/j.1365-2249.2002.02002.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2249.2002.02002.x","pdf_url":null,"source":{"id":"https://openalex.org/S11896317","display_name":"Clinical & Experimental Immunology","issn_l":"0009-9104","issn":["0009-9104","1365-2249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1906535","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1906535","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Exp Immunol","raw_type":"Text"},{"id":"pmid:12452839","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12452839","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental immunology","raw_type":"Case Reports"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/83775caf-73f0-4edf-b4f2-f6015db40ec9","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/83775caf-73f0-4edf-b4f2-f6015db40ec9","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arkwright, P D, McDermott, M F, Houten, S M, Frenkel, J, Waterham, H R, Aganna, E, Hammond, L J, Mirakian, R M, Tomlin, P I, Vijaydurai, P I & Cant, A J 2002, 'Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept', Clinical and experimental immunology, vol. 130, no. 3, pp. 484-488. https://doi.org/10.1046/j.1365-2249.2002.02002.x","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/18c74dc6-e05a-4004-aefc-be73ff10e6cb","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/hyper-igd-syndrome-hids-associated-with-in-vitro-evidence-of-defective-monocyte-tnfrsf1a-shedding-and-partial-response-to-tnf-receptor-blockade-with-etanercept(18c74dc6-e05a-4004-aefc-be73ff10e6cb).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical and experimental immunology, 130(3), 484 - 488. Wiley-Blackwell","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:1906535","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1906535","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Exp Immunol","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1596257295","https://openalex.org/W2002958081","https://openalex.org/W2018915861","https://openalex.org/W2019700846","https://openalex.org/W2047123230","https://openalex.org/W2051600615","https://openalex.org/W2062641743","https://openalex.org/W2066503618","https://openalex.org/W2081823648","https://openalex.org/W2099337172","https://openalex.org/W2134635562","https://openalex.org/W2142793611","https://openalex.org/W2153467733","https://openalex.org/W2242165656","https://openalex.org/W2316703224","https://openalex.org/W2337389349","https://openalex.org/W2469611772","https://openalex.org/W2624936342","https://openalex.org/W2803106771"],"related_works":["https://openalex.org/W2010048822","https://openalex.org/W2050325225","https://openalex.org/W1966995137","https://openalex.org/W2153467733","https://openalex.org/W2058374674","https://openalex.org/W2326331776","https://openalex.org/W2976685252","https://openalex.org/W2155123460","https://openalex.org/W2418449796","https://openalex.org/W2408946671"],"abstract_inverted_index":{"Hereditary":[0],"periodic":[1,23,66],"fever":[2,24,67],"syndromes":[3],"comprise":[4],"a":[5,96,104,117,145],"group":[6],"of":[7,16,59,107,125],"distinct":[8],"disease":[9],"entities":[10],"linked":[11],"by":[12,29,39],"the":[13,32,43,60,72,126],"defining":[14],"feature":[15],"recurrent":[17],"febrile":[18,47],"episodes.":[19],"Hyper":[20,150],"IgD":[21,151],"with":[22,71,82,153],"syndrome":[25,68,152],"(HIDS)":[26],"is":[27,53,77,158],"caused":[28],"mutations":[30,110],"in":[31,42,79,88,99,122,136],"mevalonate":[33],"kinase":[34],"(MVK)":[35],"gene.":[36],"The":[37,139],"mechanisms":[38],"which":[40,157],"defects":[41],"MVK":[44,109],"gene":[45,62],"cause":[46,65],"episodes":[48],"are":[49],"unclear":[50],"and":[51],"there":[52],"no":[54],"uniformly":[55],"effective":[56,78],"treatment.":[57],"Mutations":[58],"TNFRSF1A":[61,118,155],"may":[63],"also":[64],"(TRAPS).":[69],"Treatment":[70],"TNFR-Fc":[73],"fusion":[74],"protein,":[75],"etanercept,":[76],"some":[80],"patients":[81],"TRAPS,":[83],"but":[84],"its":[85],"clinical":[86,112,147],"usefulness":[87],"HIDS":[89,113],"has":[90],"not":[91],"been":[92],"reported.":[93],"We":[94],"describe":[95],"3-year-old":[97],"boy":[98],"whom":[100],"genetic":[101],"screening":[102],"revealed":[103],"rare":[105],"combination":[106],"two":[108],"producing":[111],"as":[114,116],"well":[115],"P46L":[119],"variant":[120],"present":[121],"about":[123],"1%":[124],"population.":[127],"In":[128],"vitro":[129],"functional":[130],"assays":[131],"demonstrated":[132],"reduced":[133],"receptor":[134],"shedding":[135],"proband's":[137],"monocytes.":[138],"proband":[140],"therefore":[141],"appears":[142],"to":[143,161],"have":[144],"novel":[146],"entity":[148],"combining":[149],"defective":[154],"homeostasis,":[156],"partially":[159],"responsive":[160],"etanercept.":[162]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}